Answers are grounded in this paper and cite their sources.
Nine of 12 patients treated in a double-blind manner with topical 1.0% lomustine had complete resolution of psoriatic plaques in four to six weeks. Local toxicity included cutaneous irritation with epidermal separation, hyperpigmentation, telangiectasia, and cutaneous pain and pruritus. Two patients developed temporary bone marrow suppression. At present, four of the 12 patients have received 18-month remissions.
No takes yet. Share an insight, caveat, or question.
Gary L. Peck (1972) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: